Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nucleonics Logo
Nucleonics CB Rank
546098
Heat Score
71
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Founded
obfuscation
PrivateSeries B Langhorne, Pennsylvania, United States11-50 nucleonicsinc.com
Biotechnology
Health Care
Medical
Overview

Nucleonics
Total Funding
obfuscation
Heat Score
71

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score
pts
in past quarter
Heat Score 71
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Nucleonics

CB Rank
546098
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Founded
obfuscation
PrivateSeries B Langhorne, Pennsylvania, United States11-50 nucleonicsinc.com
Biotechnology
Health Care
Medical

Funding Rounds

Series B
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Nucleonics inc
Operating Status Active
Company Type For Profit
About the Company
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Phone Number +1 408-780-0908
Contact Email info@nucleonics.com
Predictions & Insights

Products & Services

RNA Interference-Based Therapeutics
Therapeutic products that use RNA interference technology to modulate gene expression for treating diseases.
Biotechnology Research Reagents and Kits
A range of reagents and assay kits for molecular biology and RNA research applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B
obfuscation
Series B - Nucleonics Logo
Series B - Nucleonics
7
obfuscation
New Enterprise AssociatesSeries B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
HealthCap Logo
HealthCap
No
Series B - Nucleonics Logo
Series B - Nucleonics
Per Samuelsson
HealthCap Logo
HealthCap
No
Series B - Nucleonics Logo
Series B - Nucleonics
Per Samuelsson
HealthCap Logo
HealthCap
No
Series B - Nucleonics Logo
Series B - Nucleonics
Per Samuelsson
HealthCap Logo
HealthCap
No
Series B - Nucleonics Logo
Series B - Nucleonics
Per Samuelsson
HealthCap Logo
HealthCap
No
Series B - Nucleonics Logo
Series B - Nucleonics
Per Samuelsson
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Board Members and Advisors 2

Board Members and Advisors

News
Technology
View Tech Report

IT Spend

$7.3KThis year, Nucleonics is projected to spend $7.3K on IT, according to Aberdeen.

Active Website Tech Count

11Nucleonics is actively using 11 technologies for its website, according to BuiltWith. These include SSL by Default, LetsEncrypt, and  nginx.
Sub-Organizations
Frequently Asked Questions

Where is Nucleonics's headquarters? Nucleonics is located in Langhorne, Pennsylvania, United States.Who invested in Nucleonics? Nucleonics has 7 investors including HealthCap and  SR One.When was the last funding round for Nucleonics? Nucleonics closed its last funding round on
obfuscation
from a Series B round.Who are Nucleonics's competitors? Alternatives and possible competitors to Nucleonics may include Prime Medicine, Apple Tree Partners, and  Hoefer.How much funding has Nucleonics raised to date? Nucleonics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|